Rh(III)‐Catalyzed Asymmetric CH Activation of Sulfoximines With Iodonium Ylides Enabled by Chiral Carboxylic Acid
Advanced Synthesis & Catalysis · 01.08.2026 · 368 (15)
DOI: 10.1002/adsc.70629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 21.07.2026. Verfasst von Rihuang Pan und 3 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A chiral carboxylic acid‐assisted, rhodium‐catalyzed asymmetric CH activation of sulfoximines with iodonium ylides has been developed. A broad range of sulfur‐stereogenic sulfoximines were obtained in yields of up to 95% and with enantioselectivities of up to 97:3 er. Notably, iodonium ylides generated in situ from 1,3‐diketones and hypervalent iodine reagents were also compatible with this asymmetric reaction. The synthetic utility and practicality of this method were further demonstrated by oxidation of one product with m ‐CPBA providing the ten‐membered cyclic chiral sulfoximine. Mechanistic investigations were conducted by H/D exchange, kinetic isotope effect, intermolecular competition, and control experiments.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pan, R., Xiao, X., Zhou, L., & Lin, X. (2026). Rh(III)‐Catalyzed Asymmetric CH Activation of Sulfoximines With Iodonium Ylides Enabled by Chiral Carboxylic Acid. Advanced Synthesis & Catalysis, 368(15). https://doi.org/10.1002/adsc.70629
Vancouver
Pan R, Xiao X, Zhou L, Lin X. Rh(III)‐Catalyzed Asymmetric CH Activation of Sulfoximines With Iodonium Ylides Enabled by Chiral Carboxylic Acid. Advanced Synthesis & Catalysis. 2026;368(15). doi:10.1002/adsc.70629
BibTeX
@article{Pan2026,
author = {Pan, Rihuang and Xiao, Xinglong and Zhou, Lide and Lin, Xufeng},
title = {Rh(III)‐Catalyzed Asymmetric CH Activation of Sulfoximines With Iodonium Ylides Enabled by Chiral Carboxylic Acid},
journal = {Advanced Synthesis & Catalysis},
year = {2026},
volume = {368},
number = {15},
doi = {10.1002/adsc.70629}
}
EUVIMED